SELLAS Life Sciences Group Inc (SLS)
1.46
-0.01
(-0.68%)
USD |
NASDAQ |
May 17, 16:00
1.465
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Cash and Short Term Investments (Quarterly): 18.42M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 18.42M |
| December 31, 2023 | 2.53M |
| September 30, 2023 | 3.969M |
| June 30, 2023 | 13.81M |
| March 31, 2023 | 23.90M |
| December 31, 2022 | 17.12M |
| September 30, 2022 | 21.35M |
| June 30, 2022 | 26.99M |
| March 31, 2022 | 14.25M |
| December 31, 2021 | 21.36M |
| September 30, 2021 | 26.28M |
| June 30, 2021 | 29.92M |
| March 31, 2021 | 28.03M |
| December 31, 2020 | 35.30M |
| September 30, 2020 | 8.203M |
| June 30, 2020 | 3.34M |
| March 31, 2020 | 6.746M |
| December 31, 2019 | 7.277M |
| September 30, 2019 | 9.119M |
| June 30, 2019 | 12.75M |
| March 31, 2019 | 2.576M |
| December 31, 2018 | 5.337M |
| September 30, 2018 | 9.968M |
| June 30, 2018 | 1.349M |
| March 31, 2018 | 3.474M |
| Date | Value |
|---|---|
| December 31, 2017 | 2.319M |
| September 30, 2017 | 12.91M |
| June 30, 2017 | 18.07M |
| March 31, 2017 | 27.64M |
| December 31, 2016 | 5.962M |
| September 30, 2016 | 24.51M |
| June 30, 2016 | 19.59M |
| March 31, 2016 | 34.71M |
| December 31, 2015 | 29.73M |
| September 30, 2015 | 34.81M |
| June 30, 2015 | 45.28M |
| March 31, 2015 | 52.86M |
| December 31, 2014 | 23.65M |
| September 30, 2014 | 24.65M |
| June 30, 2014 | 39.16M |
| March 31, 2014 | 52.43M |
| December 31, 2013 | 47.79M |
| September 30, 2013 | 54.23M |
| June 30, 2013 | 26.70M |
| March 31, 2013 | 27.19M |
| December 31, 2012 | 35.48M |
| September 30, 2012 | 15.42M |
| June 30, 2012 | 19.23M |
| March 31, 2012 | 8.701M |
| December 31, 2011 | 11.43M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.53M
Minimum
Dec 2023
35.30M
Maximum
Dec 2020
16.53M
Average
15.69M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Geron Corp | 443.05M |
| Immuneering Corp | 71.28M |
| Protagonist Therapeutics Inc | 322.64M |
| Akebia Therapeutics Inc | 41.96M |
| Moderna Inc | 8.523B |